发现新型PDEδ自降解剂:对自连结化合物 (ATTEC) 的案例研究
Jingying Bao1,2, Zhenqian Chen1,2, Yu Li2
1School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China.
ACS medicinal chemistry letters
|January 17, 2024
概括
研究人员开发了新的自连接化合物 (ATTEC) 来降解PDEδ蛋白. 化合物12c有效降低了PDEδ水平,并抑制了KRAS突变胰腺癌细胞的生长,显示出抗瘤药物发现的希望.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 自联结化合物 (ATTEC) 技术为向蛋白质降解 (TPD) 提供了一种新的战略.
- 二酶三角酶 (PDEδ) 是癌症中潜在的治疗点.
研究的目的:
- 使用ATTEC方法发现第一代PDEδ自降解剂.
- 评估这些降解剂在抑制癌细胞生长中的有效性.
主要方法:
- 开发旨在诱导PDEδ降解的ATTEC化合物.
- 生物化学测试以评估PDEδ结合亲和力和降解.
- 基于细胞的测定测量PDEδ蛋白和mRNA水平.
- 在KRAS突变胰腺癌细胞系的体外研究.
主要成果:
- 化合物12c证明具有强大的PDEδ结合,并诱导度依赖的PDEδ降解.
- 降解通过溶酶体介导的自发生,而不会影响PDEδmRNA水平.
- 化合物12c显著抑制了KRAS突变胰腺癌细胞的生长,超过了PDEδ抑制剂.
结论:
- 在开发PDEδ自降解剂时,ATTEC方法是有效的.
- 有针对性的PDEδ降解是抗瘤药物发现的有希望的策略,特别是在胰腺癌中.
相关概念视频
Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
Delivery Pathways to the Lysosome
6.6K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.6K
ATP Driven Pumps III: V-type Pumps
3.7K
V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
3.7K
The Proteasome
845
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
845
Export of Misfolded Proteins out of the ER
3.6K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K


